EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Molecular analysis of Bombay phenotype cases seen in India

A. Gorakshakar, A. Donta, S. Jadhav, K. Vasanta, K. Ghosh

ISBT Science Series · 2015-11 · 10 (2) · 100-105

DOI: 10.1111/voxs.12232 ↗
AbstractBibliografische Angaben

Abstract

Background and Objectives The Bombay phenotype cases do not express the ABH antigens on red blood cells and in body secretions because of the inactivation of H ( FUT 1 ) gene and Secretor ( FUT 2 ) genes. This rare phenotype was first detected in Mumbai, India, previously known as ‘Bombay’. The presence of T725G mutation in FUT 1 gene and deletion of FUT 2 gene, both in homozygous condition, has been found to be the cause of Bombay phenotype in individuals originating from India. Thus, the objective of this study was micromapping of all the cases of Bombay phenotype identified at our Institute during the last 60 years and molecular analysis of FUT 1 and FUT 2 genes in a large number of Bombay phenotype cases. Material and Methods Bombay phenotype cases were confirmed by conventional serological techniques. FUT 1 gene in 89 cases was screened for T725G alteration by PCR – RFLP . Deletions in FUT 2 gene were detected by specific pairs of primers. Similarly, FUT 1 and FUT 2 genes were sequenced in all control samples. Results In the present series, 74·2% Bombay phenotype cases were originating from Maharashtra state. T725G was found to be the only mutation in homozygous condition in FUT 1 gene in all cases of Bombay phenotype. Similarly, they were homozygous for 10‐kb deletion covering entire FUT 2 gene. Conclusion All the cases of Bombay phenotype reported in this study, originating from different states of India, showed only T725G alteration in FUT 1 gene and 10‐kb deletion covering entire FUT 2 gene suggesting the unicentric origin of this rare phenotype in India.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →